EA200901099A1 - Соединения и способы модулирования сопряженных с g-белком рецепторов - Google Patents
Соединения и способы модулирования сопряженных с g-белком рецепторовInfo
- Publication number
- EA200901099A1 EA200901099A1 EA200901099A EA200901099A EA200901099A1 EA 200901099 A1 EA200901099 A1 EA 200901099A1 EA 200901099 A EA200901099 A EA 200901099A EA 200901099 A EA200901099 A EA 200901099A EA 200901099 A1 EA200901099 A1 EA 200901099A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- protein
- methods
- connections
- modulating
- receptors connected
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/60—Naphthoxazoles; Hydrogenated naphthoxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
В заявке описаны соединения и фармацевтические композиции на их основе, которые являются пригодными для модулирования сопряженного с G-белком рецептора 20 (GPR20), и способы применения таких соединений для лечения, облегчения или профилактики состояния, обусловленного патологическим или нерегулированным рецептором GPR20.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89117807P | 2007-02-22 | 2007-02-22 | |
PCT/US2008/050507 WO2008103501A1 (en) | 2007-02-22 | 2008-01-08 | Compounds and methods for modulating g protein-coupled receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200901099A1 true EA200901099A1 (ru) | 2010-04-30 |
Family
ID=39522201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200901099A EA200901099A1 (ru) | 2007-02-22 | 2008-01-08 | Соединения и способы модулирования сопряженных с g-белком рецепторов |
Country Status (11)
Country | Link |
---|---|
US (1) | US8394841B2 (ru) |
EP (1) | EP2125758A1 (ru) |
JP (1) | JP5175866B2 (ru) |
KR (1) | KR20090113901A (ru) |
CN (1) | CN101646660A (ru) |
AU (1) | AU2008218951B2 (ru) |
BR (1) | BRPI0807552A2 (ru) |
CA (1) | CA2677706A1 (ru) |
EA (1) | EA200901099A1 (ru) |
MX (1) | MX2009008923A (ru) |
WO (1) | WO2008103501A1 (ru) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2010014569A (es) * | 2008-06-24 | 2011-03-29 | Irm Llc | Compuestos y metodos para modular los receptores acoplados con proteina-g. |
WO2010048207A2 (en) * | 2008-10-21 | 2010-04-29 | Metabolex, Inc. | Aryl gpr120 receptor agonists and uses thereof |
AR074760A1 (es) | 2008-12-18 | 2011-02-09 | Metabolex Inc | Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico. |
JP5580834B2 (ja) * | 2009-03-11 | 2014-08-27 | Msd株式会社 | 新規イソインドリン−1−オン誘導体 |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8299117B2 (en) | 2010-06-16 | 2012-10-30 | Metabolex Inc. | GPR120 receptor agonists and uses thereof |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2970182B1 (en) * | 2013-03-14 | 2017-05-03 | Janssen Pharmaceutica NV | Bicyclic pyrrole derivatives useful as agonists of gpr120 |
CN105209444B (zh) | 2013-03-14 | 2017-12-29 | 詹森药业有限公司 | 可用作gpr120的激动剂的苯并稠合杂环衍生物 |
US10118922B2 (en) | 2013-03-14 | 2018-11-06 | Janssen Pharmaceutica Nv | GPR120 agonists for the treatment of type II diabetes |
CA2935897C (en) | 2014-02-19 | 2018-07-03 | Piramal Enterprises Limited | Compounds for use as gpr120 agonists |
US9067898B1 (en) | 2014-03-07 | 2015-06-30 | Janssen Pharmaceutica Nv | Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes |
US8912227B1 (en) | 2014-03-07 | 2014-12-16 | Janssen Pharmaceutica Nv | Bicyclic pyrrole derivatives useful as agonists of GPR120 |
AU2015293541B2 (en) | 2014-07-25 | 2019-11-21 | Piramal Enterprises Limited | Substituted phenyl alkanoic acid compounds as GPR120 agonists and uses thereof |
AU2015313829B2 (en) | 2014-09-11 | 2020-07-23 | Piramal Enterprises Limited | Fused heterocyclic compounds as GPR120 agonists |
WO2016105118A2 (ko) * | 2014-12-24 | 2016-06-30 | 주식회사 엘지생명과학 | Gpr120 효능제로서의 바이아릴 유도체 |
AU2016213929C1 (en) | 2015-02-05 | 2020-05-28 | Piramal Enterprises Limited | Compounds containing carbon-carbon linker as GPR120 agonists |
CN105477451A (zh) * | 2016-01-08 | 2016-04-13 | 董仲璧 | 一种治疗癌症及癌症疼痛、发热的中药组合物 |
WO2018049324A1 (en) | 2016-09-12 | 2018-03-15 | Numerate, Inc. | Monocyclic compounds useful as gpr120 modulators |
EP3509588B1 (en) | 2016-09-12 | 2023-06-07 | Integral Health,Inc. | Bicyclic compounds useful as gpr120 modulators |
CN107089977B (zh) * | 2017-07-09 | 2018-07-31 | 王善梅 | 一种用于治疗艾滋病的药物及其制备方法 |
CA2995617A1 (en) * | 2017-11-03 | 2019-05-03 | Universite De Montreal | Heterocyclic mitochondrial activity inhibitors and uses thereof |
CN113956213A (zh) * | 2021-11-19 | 2022-01-21 | 烟台药物研究所 | 一类2,4-二取代噻唑结构的PPARα/δ双重激动剂及其应用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU510758B2 (en) | 1976-01-19 | 1980-07-10 | The Dow Chemical Company | P-benzylaminobenzoic acids |
US5591862A (en) | 1993-06-11 | 1997-01-07 | Takeda Chemical Industries, Ltd. | Tetrazole derivatives, their production and use |
JP3466273B2 (ja) * | 1993-06-11 | 2003-11-10 | 武田薬品工業株式会社 | テトラゾール誘導体、その製造法およびそれを含んでなる医薬 |
EP0786457B1 (en) | 1994-10-14 | 2002-05-29 | Yamanouchi Pharmaceutical Co. Ltd. | Azole derivatives |
GB2328975A (en) * | 1997-09-03 | 1999-03-10 | Ford Global Tech Inc | Combustion engine with internal EGR |
ATE451346T1 (de) * | 1998-03-10 | 2009-12-15 | Ono Pharmaceutical Co | Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten |
GB9914977D0 (en) * | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
EP1630152A4 (en) | 2003-05-30 | 2009-09-23 | Takeda Pharmaceutical | CONNECTION WITH CONDENSED RING |
JP4805552B2 (ja) * | 2003-05-30 | 2011-11-02 | 武田薬品工業株式会社 | 縮合環化合物 |
EP1688138A4 (en) | 2003-11-26 | 2008-01-16 | Takeda Pharmaceutical | AGENT FOR REGULATING THE FUNCTION OF A RECEIVER |
CN1946666A (zh) | 2004-02-27 | 2007-04-11 | 埃姆艮股份有限公司 | 用于治疗代谢性疾病的化合物、药物组合物和方法 |
EP1747454A1 (en) | 2004-05-04 | 2007-01-31 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method of analysis using chromatographic pre-separation |
PE20060362A1 (es) | 2004-05-24 | 2006-05-15 | Irm Llc | Compuestos de oxazol como moduladores de ppar |
PE20060315A1 (es) * | 2004-05-24 | 2006-05-15 | Irm Llc | Compuestos de tiazol como moduladores de ppar |
CN101304983A (zh) * | 2005-11-07 | 2008-11-12 | Irm责任有限公司 | 作为ppar调节剂的化合物和组合物 |
-
2008
- 2008-01-08 EA EA200901099A patent/EA200901099A1/ru unknown
- 2008-01-08 US US12/527,849 patent/US8394841B2/en not_active Expired - Fee Related
- 2008-01-08 JP JP2009550949A patent/JP5175866B2/ja not_active Expired - Fee Related
- 2008-01-08 MX MX2009008923A patent/MX2009008923A/es not_active Application Discontinuation
- 2008-01-08 WO PCT/US2008/050507 patent/WO2008103501A1/en active Application Filing
- 2008-01-08 AU AU2008218951A patent/AU2008218951B2/en not_active Ceased
- 2008-01-08 BR BRPI0807552-2A patent/BRPI0807552A2/pt not_active IP Right Cessation
- 2008-01-08 KR KR1020097019654A patent/KR20090113901A/ko active IP Right Grant
- 2008-01-08 EP EP08727424A patent/EP2125758A1/en not_active Withdrawn
- 2008-01-08 CA CA002677706A patent/CA2677706A1/en not_active Abandoned
- 2008-01-08 CN CN200880003906A patent/CN101646660A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
MX2009008923A (es) | 2009-08-28 |
EP2125758A1 (en) | 2009-12-02 |
WO2008103501A1 (en) | 2008-08-28 |
AU2008218951B2 (en) | 2011-11-17 |
CA2677706A1 (en) | 2008-08-28 |
JP2010519306A (ja) | 2010-06-03 |
US8394841B2 (en) | 2013-03-12 |
JP5175866B2 (ja) | 2013-04-03 |
BRPI0807552A2 (pt) | 2014-07-01 |
US20100035944A1 (en) | 2010-02-11 |
AU2008218951A1 (en) | 2008-08-28 |
KR20090113901A (ko) | 2009-11-02 |
CN101646660A (zh) | 2010-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200901099A1 (ru) | Соединения и способы модулирования сопряженных с g-белком рецепторов | |
EA200901098A1 (ru) | Производные тиазола в качестве модуляторов сопряженных с g-белком рецепторов | |
WO2009061652A8 (en) | Compounds which modulate the cb2 receptor | |
WO2007005887A3 (en) | Androgen receptor modulator compounds, compositions and uses thereof | |
NO20090624L (no) | Forbindelser som modulerer CB2 receptoren | |
DK2060570T3 (da) | Som modulatorer af dopamin-d3-receptorer anvendelige azabicyclo(3.1.0)hexanderivater | |
WO2008042571A3 (en) | Substituted indole compounds | |
CL2007002595A1 (es) | Compuestos derivados de n-(1-hetaril-piperidin-4-il)-(het)arilamida, moduladores del receptor ep2; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos de la fertilidad, trastornos menstruale | |
CR10694A (es) | Compuestos antagonistas del receptor de glucagon, composiciones que contienen dichos compuestos y procedimientos de uso | |
WO2003062209A3 (en) | Substituted quinazolin-4-ylamine analogues as modulators of capsaicin | |
ATE526318T1 (de) | Farnesoid-x-rezeptor-agonisten | |
EA200901653A1 (ru) | ОПОСРЕДУЕМОЕ PHKi ИНГИБИРОВАНИЕ ЭКСПРЕССИИ АЛЬФА-EnaC | |
CL2008001049A1 (es) | Compuestos derivados de benzamidas sustituidas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la diabetes, intolerancia a la glucosa, dislipidemia, hipertension, obesidad. | |
BRPI0919172A2 (pt) | compostos os quais modulam seletivamente o receptor de cb2 | |
NO20074002L (no) | Androgen reseptor-modulatorforbindelser og fremgangsmater | |
IN2012DN02876A (ru) | ||
UY31622A1 (es) | Antagonistas de aminoalquilbifenilo n,n-disubstituidos de receptores de prostaglandina d2 | |
NO20070379L (no) | Kjemiske forbindelser | |
BRPI0815750A2 (pt) | processo para recuperar um solvente orgânico e um etanol orgânico de uma mistura de etanol/água. | |
HN2010000352A (es) | Derivados de ciclopropilamida 978 | |
ATE421518T1 (de) | Dihydrochinazolinone als 5ht-modulatoren | |
NO20074277L (no) | Kinnolinforbindelser og anvendelse derav som lever X reseptor modulatorer | |
DK2099784T3 (da) | 1,5-diphenyl-3-pyridinylamino-1,5-dihydrioyrrolidin-2-on som cb1-receptor-modulatorer | |
MX2007004661A (es) | Derivados de 1-(hetero)aril-3-amino-pirrolidina para usarse como antagonistas del receptor mglur3. | |
HK1150285A1 (en) | Organic photosensitive optoelectronic devices containing tetra- azaporphyrins |